Statement by Mr. Nicolas Sarkozy, President of the Republic, on the fight against Alzheimer's disease, in Sophia Antipolis on February 1, 2008.

France Nicolas Sarkozy · President of France

1 February 2008 · Launch of the Alzheimer Plan · Sophia Antipolis, France

Context
Sarkozy addressed researchers and officials in Sophia-Antipolis on February 1, 2008, to officially launch France's five-year national Alzheimer Plan.
Main themes
Alzheimer's disease, national Alzheimer Plan, state commitment and funding, patient and caregiver support, medical research, interministerial coordination, care system reform, European health cooperation, solidarity with vulnerable seniors, plan monitoring and evaluation
Duration
~35 min
87th percentile
Words
4,151
87th percentile
Sentences
267
94th percentile
Readability
56
78th percentile
Grade
9.3
14th percentile
Syntax
2.64
9th percentile
Vocabulary
2.22
54th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 69%69%
  • Institutional 12%12%
  • Economic 9%9%
  • Ceremonial 5%5%
  • Technological 5%4%
  • Geopolitical 1%1%
  • Environmental 0%0%
  • Not in focus 0%

267 sentences in 47 paragraphs

Ladies Ministers,

Mr. Minister,

Ladies and Gentlemen,

It is both an honor and a pleasure to be among you today to launch the Alzheimer Plan. This is a moment awaited by all, I know. Impatience has been expressed here and there. I understand it. How could it be otherwise? When the suffering of a loved one resonates throughout an entire family, I know that one can no longer wait and that every day counts. Today, there will therefore be an Alzheimer Plan, for five years. It is a sustainable commitment from the State in an unrelenting fight that we will wage against this disease. It is a personal commitment that I will oversee.

I am particularly happy to be in Sophia-Antipolis, a high place of excellence in education and research in our country, in a department, dear Christian ESTROSI, that did not wait for the Alzheimer Plan to be at the forefront of the fight against the disease. In the face of suffering, in a certain form of fatalism, there are exceptional actions on the ground, there are treasures of humanity, there are countless dedications to our most vulnerable seniors. But that is not enough. The Alzheimer Plan pays tribute to the actions of all, but it must multiply France's efforts against this disease.

Last September, I established the Commission chaired by Professor Joël MENARD, whose work and presence I salute. The members of the Commission and the technical groups worked tirelessly for two months, and on November 8, Professor MENARD submitted his report to me, a remarkable piece of work, Roselyne BACHELOT will not contradict me. The Commission's report is exceptionally rich and precise. It perfectly captured the need for a comprehensive approach to the person and their caregivers. It showed very well that the care system must be organized around the patient and their family. Unfortunately, it is often the opposite that happens: the patient and their loved ones search, fumble, wander, and in the meantime, the disease wreaks havoc.

The Alzheimer Plan that we are presenting is strongly inspired by the report of the Commission chaired by Professor MENARD. From the moment this report was submitted, the relevant administrations worked on the development of the Plan. I want to thank Roselyne BACHELOT, Valérie PECRESSE, Valérie LETARD who also worked tirelessly. We conducted a thorough analysis of the MENARD report and we carried it out in consultation. It would have been easy to announce a Plan hastily, without figures, without a timeline, but I like to be criticized six days a week for going too fast, and the last day for not going fast enough. I tried to go at the speed necessary to announce a credible plan. I wanted this Alzheimer Plan to be made methodically. The work of developing the Plan is now complete.

Now everything begins. The time for action has come. I have decided that an interministerial mission officer will animate and coordinate the implementation of the Plan. I thank Florence LUSTMAN, Inspector General of Finance, for accepting this mission. This is essential. She will be the guarantor of the complete realization of the measures provided for in the Alzheimer Plan that I will present. She will be the guarantor of the results. She will be the relay of the Ministers' actions. Together with the Ministers, you will carry the banner of the fight against Alzheimer's disease, particularly during the French presidency of the European Union because our focus, Roselyne, is to make the fight against this disease a European issue. All countries are affected; we cannot simply retreat behind our borders, ignoring the progress or difficulties of others.

You will ensure, Madam, that this plan concretely improves the lives of patients and their loved ones. You will also pay attention to the scaling up of the Plan until 2012. It is a five-year Plan; we will establish indicators that will allow us to monitor the execution of the Plan step by step. We will evaluate the entire Plan starting in 2011. I am fully aware that many hopes are placed in the actions of the ministers, in your actions, Madam, and in mine.

We must face a disease that is much more than a dysfunction. Alzheimer's disease and related diseases are a fracture in human existence.

A fracture because Alzheimer's disease is the otherness that we do not want to see as it is. It is more comfortable to live in the ignorant individualism of the other. Alzheimer's disease demands solidarity and not resignation.

A fracture because Alzheimer's disease plays with time. It makes the past unbearable for the patient and the present unbearable for the caregivers. When will this disease take my wife, my husband, my mother, my father? This question is posed by every family every day.

A fracture because Alzheimer's disease seems to resist our dream of omnipotence. This disease plays hide and seek with researchers. The most promising leads today may tomorrow be dead ends.

What is the spirit of the Alzheimer Plan, in the face of all these difficulties?

We first wanted this to be a shared effort between preparing for the future, for diagnostics and treatments, and taking into account the sick individuals, who are increasingly numerous. We have a double challenge: more and more patients to take care of right away, and more and more resources to be allocated so that there are fewer and fewer patients in the future. We are exactly in a scissor effect. We must not and cannot neglect the present on the grounds that we need to prepare for the future. And France must hold its place in diagnostic and therapeutic innovation. France must contribute to shifting Alzheimer, in 10 or 15 years, into the realm of diseases whose progression can be stabilized. In a few years, I hope, we will no longer suffer as we do today - perhaps even we will no longer die - from Alzheimer's disease.

The hallmark of the Alzheimer Plan is the integration of research, Valérie, health, Roselyne, and solidarity, the other Valérie. It is that we are at the confluence of the actions of several ministries that must work together. This is how the Alzheimer Plan was conceived. Research must improve care and support. Care must be organized coherently with home assistance or institutional care, Christian. Helping the sick person is a whole; it is not a series of successive technical acts.

The Alzheimer Plan prioritizes the human aspect. We wanted to place the sick person at the heart of the Plan. It is the honor of a civilization to provide help and protection to those who have become, day by day, true "living wallers." It is the honor of a civilization to tirelessly weave the bonds between generations. Looking at the patients I have seen, I thought: one day this could be us, this could be me. That is why I decided, and I stand by it, to create medical co-payments. It was not the easiest decision. But to all those who demand more resources from me, I would like to say, I ask you for more solidarity to understand that I cannot create resources if I do not make courageous decisions. The medical co-payments are the expression of responsibility and solidarity: responsibility, because it is never easy to create new leeway. Where to find the money? Solidarity, because this leeway will allow us to finance the new needs arising from the increase in human longevity. We will need more resources. And presenting a plan without presenting the means, I do not see how we can do that? To all those who do not have the courage to accept the choice we made for new revenues, I say: tell the French, since you do not want this additional revenue, how do you find the money? That is also the credibility of the Plan.

I also thank the parliamentarians who voted for this measure. It is so easy to ask for more spending: but here everyone is responsible - when there is already not enough and when health insurance is in deficit. Without additional resources, how do we do it? Thanks to what we have taken on, it may not be the easiest decision, we are mobilizing 300 million Euros of new spending as of 2008 for the Alzheimer Plan, and it will be 500 million Euros in 2012. In total, it is one billion six hundred million Euros that will be spent additionally in the fight against Alzheimer's disease. Who can tell me that this is not necessary? Without the co-payments, it would have been an additional deficit. That is the truth. We must face it, and I say it weighing my words: I wanted this priority.

This amount is considerable, one billion six hundred million Euros. It is a major financial commitment that should not be made at the expense of the health insurance accounts, which are already in deficit. Can we continue to add necessary additional expenses without providing additional resources? That is why the medical co-payments were implemented on January 1st. So why talk about co-payments? I talk about co-payments because if I wanted additional revenues and I stand by it, it is to be able to present to you, credibly, additional expenses. How can we present additional expenses without additional revenues? I know well, my friends tell me: "don't talk too much about co-payments, talk about expenses." Well, yes, I talk about it! Because to those who do not want co-payments, let them come and tell the French how we pay for the additional expenses. It is an unavoidable debate. I did not want to leave families alone in the face of this drama. I did not want to tell research: "manage with constant means" because you know well that it is not possible.

In addition to Alzheimer's disease, we will finance other health priorities: the fight against cancer, because we will not abandon the fight against cancer - because we fight against Alzheimer naturally - and then something, Roselyne knows very well, that touches me very deeply, is the development of palliative care. I do not accept the idea that compatriots who are so seriously ill cannot die with a minimum of respect and dignity. That is what palliative care centers are for. There are not enough of them. Therefore, we need more.

I will have the opportunity to specify the directions I intend to give to the Government's action in these two areas, cancer and palliative care. My priority will be the same as for Alzheimer's disease: beyond means, techniques, resources, structures, and numbers, there is the person who suffers and who can no longer bear it, and who must be placed at the heart of these various plans.

On September 21, 2007, for World Alzheimer's Day, I met with the France Alzheimer association, whose president, Mrs. Arlette MEYRIEUX, I salute. On that occasion, I outlined the main orientations of the fight against the disease. I must today clarify its content through the four objectives of the Alzheimer Plan.

The Plan's first objective is to better understand the disease, because if we do not know it better, we cannot act. France will make an unprecedented effort in research. I am fully aware that we have a delay to catch up. France's share in high-quality scientific publications on Alzheimer's disease is barely over 3% while France's share in global biomedical research is 6%. We will close this gap.

A scientific cooperation foundation will be created to give new momentum to research on Alzheimer's disease. Attached to INSERM, this foundation will aim to attract the best French and foreign researchers and to support the best teams. It will need to develop partnerships with private actors. I think of health industry players. The initial contacts that have been made indicate that the prospects for public-private cooperation are promising. I am pleased about that. Given the scale of the challenge, we cannot afford to work in isolation.

The foundation will finance the expensive equipment that research needs to advance. It will strengthen the links between basic research and clinical research, in this logic of integration that underpins the Alzheimer Plan. It will be one of the first concrete realizations of the policy of excellence that I wish for our country's research. Between 2008 and 2012, 200 million Euros will be allocated for Alzheimer's research. I expect the foundation to help us achieve the objective I set when establishing the Commission chaired by Professor MENARD: the discovery or validation of a diagnosis and treatment in France. That is the goal. I expect the foundation to fully leverage the synergies between research organizations, universities, hospitals, and the business world. We all come together to find solutions, and we will find them.

The Alzheimer Plan will also strengthen research in social sciences. It is indeed the entire range of care methods, both medical and social, that must be advanced and evaluated.

The action of the Scientific Cooperation Foundation must always be guided by the principle of respect for the sick person. I want patients and their families to be involved in defining the directions of research policy. The consent of patients to clinical studies must receive particular attention, given the state of consciousness of the said patients.

The second objective of the plan is to better support patients and their families around the onset of the disease. I want the Plan to enable the patient and their family to cushion the shock of learning about the disease.

Diagnostic structures will be developed. 38 memory consultations and 3 memory resource and research centers will be created by 2012. The Alzheimer Plan must reduce the waiting times to obtain an appointment and receive a diagnosis.

Furthermore, a system for announcing the disease will be established. This announcement must not be a blunt instrument. It must not be a shot fired at close range, as is the case: "Madam, Sir, you have Alzheimer’s." To understand each other and out of simple humanity, one must take their time. The announcement is a process that must unfold over time, requiring consultation among professionals. The announcement must be accompanied by precise information on the management of the disease. The essential thing is not to leave the patient alone in the face of the diagnosis and to avoid confusing the diagnosis with the prognosis. What I say about Alzheimer’s applies to cancers and everything else. There would be nothing worse. In the face of a disease without a true treatment, it is an imperative duty to explain, reassure, and guide the patient and their entourage.

The announcement must lead to support. Again, the Alzheimer Plan aims to integrate the approaches. The announcement and information about the support for the patient must go hand in hand. That is why we will create houses for the autonomy and integration of Alzheimer’s patients. These will be the single entry point for families into the care system. They will be based on the experience gained by the departments. The Alzheimer Plan aims to build, based on the know-how of the departments, a place for information and coordination of the care for sick individuals. In practice, families will be able to meet with doctors and social workers to advise and guide them. The houses for the autonomy and integration of Alzheimer’s patients will not be an additional administrative layer. They will enhance what works well on the ground thanks to the departments and the national solidarity fund for autonomy. Ultimately, these houses will be an anchor point for families. Departments and their partners will need to communicate strongly about this system. The first experiments will be conducted as early as 2008. We do not have time to wait.

I want the first experiments to be coupled with the deployment of a national phone number to inform families and direct them to the houses of autonomy.

I want the first experiments to be coupled with the deployment of a national phone number to inform families and direct them to the houses of autonomy. There needs to be a national phone number that directs families to local structures. Informing and guiding must be integrated to improve the quality of life for patients and caregivers.

The announcement of the disease to young people will be accompanied by specific support. A national reference center for young patients, designed on the model of centers dedicated to rare diseases, will be created. It must allow for the early identification of affected individuals to prevent them from wandering, which only worsens the disease. Everything shows that the earlier the diagnosis is made, the more likely we are to maintain the patient’s autonomy. We owe young patients specific care. For these patients, we must move from the chaos they currently experience to an organized care offer. I am fully aware that the challenge is immense. I want to meet it. It is not the same when you are 60 years old and you are told you have the disease, as when you are in your eighties.

The third objective of the Plan is to improve the quality of life for patients and caregivers over time once the diagnosis is established. I know that this is where the strongest expectations lie. I realize that the needs are infinite. These unlimited needs require a human, organized response.

The priority is to adapt the home or care facility to the specific needs of Alzheimer’s patients. The Plan will promote the intervention of occupational therapists and psychomotor therapists to adapt the home. We must do everything possible to allow patients to live at home, as that is their wish. In facilities, 30,000 places will be reinforced with staff to provide patients with appropriate care and activities. We need to better take into account the uniqueness of patients who wander or exhibit confusing behaviors. Appropriate care reduces their behavioral issues and the use of medication. It is not a solution to sedate them like a chemical straitjacket. It is about their quality of life. The solution is certainly not restraint or isolation. The solution is appropriate and intelligent care.

Crises may arise that require even more specialized care. Because we realize that within Alzheimer’s disease, there are many different situations, and that is the difficulty of the plan, that it must respond to all these different situations. Today, individuals with the disease who go through a crisis episode end up where? In the hospital emergency room. This is unacceptable. Unacceptable for them and unacceptable for the hospital, which is already overwhelmed. We will plan for this. The Plan provides for the creation of specialized Alzheimer units in medium-stay facilities to better manage crises.

These resource enhancements will not be sufficient; we all know that already. We could plan for ten times more. Some might rightly argue that it is still not enough. But I want and must move away from the logic of "always more." A Plan is not "always more." The Alzheimer Plan, I want it to enhance the performance of what exists, to value what the actors on the ground have developed. The resource enhancements will only be sufficient - and we have planned for 1.6 billion euros - if they are implemented coherently. This is indeed one of the first problems highlighted by the commission chaired by Professor MENARD, the lack of coherence. They must be implemented coherently for the benefit of the patient. One of the main innovations will be the establishment of the role of coordinator. This person will be the conductor of the overall care of the individual. They will organize the intervention of doctors and medical-social professionals around the patient. This measure is innovative because it integrates the different professions in service of the one who suffers. Once again, it is the system that must adapt; we must adapt it to the individual, and not the other way around, where the individual must adapt to the system. Willing departments will be able to implement the first coordinators as early as this year.

To help patients in the long term at home, we must support caregivers. The development of respite care structures will be accompanied by addressing the issue of transporting the patient to these institutions. Furthermore, the doctor in charge of the sick person must pay particular attention to the endurance capacities of caregivers. The strength of a chain lies in its weakest link. It is pointless to care for the sick person if the caregiver's capacity for endurance erodes in silence. The same logic must prevail, that of a holistic approach.

Finally, the Alzheimer Plan has a fourth objective, which is its ethical requirement. Ethics is not an accessory to look good. Ethical concern and respect for the person must be omnipresent in the practice of professionals and the living spaces of patients. I want ethical reflection to thrive and spread. Specific resources will be dedicated to this end.

From ethical questioning will emerge many legal questions. The Alzheimer Plan must provide just answers to the sensitive question of consent for the person with Alzheimer’s disease, particularly at the time of their entry into an institution. We cannot want to place the person at the heart of action and allow ourselves to sidestep this essential question. We have a unique opportunity to address this question in consultation.

Other measures are included in the Alzheimer Plan. I do not want to mention them all here. But the few actions I have mentioned seem emblematic of our will.

Is Alzheimer’s disease an affront to our dignity as humans? Then let us collectively respond with a surge of humanity.

Does Alzheimer’s disease resist science? Then let us fight and help researchers combat this disease.

Is Alzheimer’s disease a devastating evil? Then like all other scourges, we will overcome this one. May the Alzheimer Plan provide us with the energy to restore justice and dignity to our elders. I add that I will chair a meeting every six months with the relevant ministers to evaluate the results of the Alzheimer Plan; if we have made mistakes, we will change. If we have not allocated enough, we will allocate more. If there are things to modify, we will modify them. But I want France to be exemplary in research on this disease and in the treatment of patients affected by it.

Ladies and Gentlemen, I am fully aware that this is an unprecedented challenge, as rarely has a health challenge been presented to a country like ours. I add that within the framework of the necessary reorganization of the hospital map, together with Roselyne BACHELOT, we will link this reorganization with the Alzheimer Plan. A number of hospitals will need to evolve towards medium and long stays. And within medium stays, in particular, we want to develop units to care for Alzheimer’s patients. The matter is coherent, and from this point of view, I know perfectly well that more places are expected of us. So, you see, I have tried to present, along with the ministers, a comprehensive plan that does not oppose the patient and caregivers, the present and the future, research and support, but that mobilizes everyone towards a single objective: to find the means to stop this disease. To ensure that those who have it today live as well as possible without leaving anyone behind, without leaving anyone alone, whether they are caregivers or patients. You see, Madam, the task ahead of you is particularly heavy, but you will have the support of Roselyne BACHELOT, Valérie PECRESSE, Valérie LETARD, and, if you will, my support. I am confident that you will achieve results.

Ladies and Gentlemen, I believe I have demonstrated to you that France has grasped the magnitude of the challenge that lies ahead. I know very well that the fight is just beginning, and I tell researchers, doctors, and all those who among the first, especially in France, understood that it was serious, even very serious, that we will support them with an unprecedented research effort. And you have also understood that it was important to me to provide you with these answers. I have the feeling that your impatience has been real, and objectively, in eight months, mobilizing what we have mobilized, finding the logic of a coherent plan while the challenges within this disease are absolutely multiple because the situations are all different, at least be assured that your country is mobilized to help you, that not a single one of you will be left alone. Once again, I believe in this plan, but I will not hesitate to change it if the evaluation shows that we have omitted any element that would prove necessary for the effectiveness of the health action we must undertake. And believe me, my goal is that in five years, we will say that considerable progress has been made in research and support. Thank you.